April 11, 2014
The Federal Circuit on Friday upheld a lower court's decision invalidating two patents owned by Hoffmann-La Roche Inc. for the osteoporosis drug Boniva, ruling that they would be obvious in view of prior art in a victory for several generics makers.
December 06, 2013
Hoffmann-La Roche Inc. pushed a Federal Circuit panel on Friday to resurrect two of its patents covering the osteoporosis drug Boniva despite protests from several generic-drug makers, maintaining there was nothing in the record to support the lower court's obviousness finding.